Immunoregulatory role ofJα281 T cells in aged mice developing lupus-like nephritis

European Journal of Immunology

Volumn 37, Issue 2, 2007, Pages 425-433

  Sireci, Guido ^a   Russo, Domenica ^b   Dieli, Francesco ^a   Porcelli, Steven A ^c   Taniguchi, Masaru ^d   La Manna, Marco Pio ^a   Di Liberto, Diana ^a   Scarpa, Francesco ^a   Salerno, Alfredo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Autoimmunity; Knockout; NKT cells

Indexed keywords

CARDIOLIPIN; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; T LYMPHOCYTE RECEPTOR; AUTOANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; GLOMERULONEPHRITIS; HISTOPATHOLOGY; KNOCKOUT MOUSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEINURIA; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; AGING; ANIMAL; B LYMPHOCYTE; BLOOD; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; NATURAL KILLER CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGING; ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; SPLEEN;

EID: 33947732677     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636695     Document Type: Article

References (42)

1. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 1989. 143: 103-112.
2. Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E. and Hahn, B. H., T cell determinants from autoantibodies to DNA can upregulate autoinummity in murine systemic lupus erythematosus. J. Exp. Med. 1995. 181: 2017-2027.
3. Peng, S. L., Madaio, M. P., Hayday, A. C. and Craft, J., Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 1996. 157: 5689-5698.
4. Singh, R. R., Hahn, B. H. and Sercarz, E. E., Neonatal peptide exposure can prime T cells, and upon subsequent immunization induce their immune deviation: Implications for antibody- vs T cell-mediated autoimmunity. J. Exp. Med. 1996. 183: 1613-1621.
5. + T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 2001. 166: 6452-6457.
6. Singh, R. R., Ebling, F. M., Albuquerque, D. A., Saxena, V., Kumar, V., Giannini, E. H., Marion, T. N. et al., Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 2002. 169: 587-594.
7. H-derived MHC class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 2002. 196: 731-741.
8. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 1996. 156: 4035-4040.
9. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001. 44: 1127-1138.
10. Oishi, Y., Sumida, T., Sakamoto, A., Kita, Y., Kurasawa, K., Nawata, Y., Takabayashi, K. et al., Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 2001. 28: 275-283.
11. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 2001. 100: 144-148.
12. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: Development, specificity and function. Annu. Rev. Immunol. 1997 15: 535-562.
13. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C., Zhou, D., Saint-Mezard, P. et al., Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525-529.
14. Porcelli, S. A. and Modlin, R. L., The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999. 17: 297-329.
15. Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y. et al., Murine CD1d-restricted T cell recognition of cellular lipid. Immunity 2000. 12: 211-221.
16. Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E. Yamaji, K. et al., Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 1995. 38: 2176-2187.
17. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. et al., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
18. Karadimitris A., Gadola, S., Altamirano, M., Brown, D., Woolfson, A., Klenerman, P., Chen, J. L. et al., Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 2001. 98: 3294-3298.
19. Stanic, A. K., De Silva, A. D., Park, J. J., Sriram, V., Ichikawa, S., Hirabyashi, Y., Hayakawa, K. et al., Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by β-d-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 2003. 100: 1849-1854.
20. Hammond, K. J. and Godfrey, D. I., NKT cells: Potential targets for autoirrumme disease therapy?. Tissue Antigens 2002. 59: 353-363.
21. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O., Miura, T. et al., The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 1052-1056.
22. Wang, B., Geng, Y. B. and Wang, C. R., CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 2001. 194: 313-320.
23. Singh, R. R., Saxena, V., Zang, S., Li, L., Finkelman, F. D., Witte, D. P. and Jacob, C. O., Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J. Immunol. 2003. 170: 4818-4825.
24. Yang, J. Q., Saxena, V., Xu, H., Van Kaer, L., Wang, C. R. and Singh, R. R., Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-1pr/1pr mice. J. Immunol. 2003. 171: 4439-4446.
25. Satoh, M. and Reeves, W. H., Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 1994. 180: 2341-2346.
26. Richard, H. B., Satoh, M., Jennette, J. C., Croker, B. P., Yoshida, H. and Reeves, W. H., Interferon-γ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 2001. 60: 2173-2180.
27. Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S. and Van Kaer, L., CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997. 6: 469-477.
28. Yang, J.-Q., Singh, A. K. Wilson, M. T. Satoh, M. Stanic, A. K., Park, J.-J. and Hong, S. et al., Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J. Immunol. 2003. 171: 2142-2153.
29. 1 mice. J. Immunol. 2005. 175: 763-770.
30. Martin, F., Kearney, J.F., Marginal-zone B cells. Nat. Rev. Immunol. 2002. 2: 323-335.
31. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual V., Interferon and granulopoiesis signatures in systemic lupus erythernatosus blood. J. Exp. Med. 2003. 197: 711-723.
32. + T cells: Their cytokine production and hepatotoxicity in vivo and in vitro. J. Immunol. 2002. 169: 6127-6132.
33. Tsukahara, A., Seki, S. Iiai, T. Moroda, T. Watanabe, H. Suzuki, S., Tada, T. et al., Mouse liver T cells: Their change with aging and in comparison with peripheral T cells. Hepatology 1997. 26: 301-309.
34. lpr mice: An example of disease regulation at the organ level. J. Immunol. 2001. 167: 2985-2990.
35. Zeng, D., Dick, M., Cheng, L., Amano, M., Dejbakhsh-Jones, S., Huie, P., Sibley, R. and Strober, S., Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: Role of cytokines. J. Exp. Med. 1998. 187: 525-530.
36. Zeng, D., Lee, M. K., Tung, J., Bredolan, A. and Strober, S., A role of CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 2000. 164: 5000-5004.
37. Wallace, D. J., The clinical presentation of systemic lupus erythematosus. In: Wallace, D. J. and Hahn, B. H. (Eds.) Dubois' Lupus Erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia 2002: 621-641.
38. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 2003. 15: 279-288.
39. Li, Y., Li, H. and Weigert, M., Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 2002. 195: 181-188.
40. 1 mice. Clin. Immunol. 2000. 94: 51-63.
41. Peralbo, E., Delarosa, O., Gayoso, I., Pita, M. L., Tarazona, R. and Solana, R., Decreased frequency and proliferative response of invariant Valpha24V-beta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology. 2006. 7: 483-492.
42. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y. et al., Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.